News Allakos Inc.

Equities

ALLK

US01671P1003

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
1.01 ^USD	-0.98%		-4.72%	-63.00%

Mar. 15	North American Morning Briefing : Inflation Worries Continue to Weigh on Mood	DJ
Mar. 14	Allakos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Inflation Worries Continue to Weigh on Mood	Mar. 15	DJ
Allakos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	Mar. 14	GL
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	Mar. 14	AQ
Allakos Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 14	CI
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024	Feb. 26	GL
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024	Feb. 26	AQ
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition	Feb. 12	GL
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition	Feb. 12	AQ
Allakos Inc. Announces Publication Highlighting AK006 Mast Cell Inhibition	Feb. 12	CI
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK	Feb. 07	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK	Jan. 30	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc. - ALLK	Jan. 22	PR
North American Morning Briefing : TSMC Results -2-	Jan. 18	DJ
Sector Update: Health Care Stocks Slipping Late Afternoon	Jan. 17	MT
Sector Update: Health Care	Jan. 17	MT
Top Midday Decliners	Jan. 17	MT
Allakos Shares Fall After Downgrades by Jefferies, Cantor Fitzgerald, Lifesci Capital	Jan. 17	MT
JMP Securities Adjusts Allakos' Price Target to $3 From $10, Maintains Market Outperform Rating	Jan. 17	MT
Barclays Trims Allakos' Price Target to $1 From $1.50, Maintains Underweight Rating	Jan. 17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Allakos Inc.

Equities

ALLK

US01671P1003

Summary

Filters